Noosa News
Experts hail addition of two more vaccines to nation’s virus portfolio
Rather, Dr Griffin said, it boosted Australia’s “vaccine portfolio”.
“This gives us additional options and given they’re slightly different technologies they’re very complimentary to the two vaccines we already have an agreement for,” he said.
The vaccine candidates secured by Australia
Newly announced:
- Novavax- 40 million doses – currently in stage 2 and 3 clinical trials
- Pfizer- 10 million doses – currently in stage 2 and 3 clinical trials
Previously announced:
- UQ/CSL – 51 million doses – currently in an expanded stage 1 clinical trial
- University of Oxford/ AstraZeneca – 33.8 million doses – currently in stage 2 and 3 clinical trials
“Having an arrangement now for four vaccines gives us a better chance of having a vaccine…
Continue Reading
